Latest news

Orchard Therapeutics announces today that it has entered into a strategic alliance with Oxford BioMedica plc, a world-leading company in gene and cell therapy.

Orchard Therapeutics Limited and researchers from the UCLA Broad Stem Cell Research Center, led by Orchard Scientific Advisory Board member Dr. Donald Kohn have been awarded $20 million by the California Institute for Regenerative Medicine’s governing board (CIRM).

Dr Andrea Spezzi, CMO, R&D Head and co-founder of Orchard Therapeutics, has been named as one of the women changing the face and future of healthcare in the BioBeat 50 Movers and Shakers in the BioBusiness 2016 report.